A functional insertion/deletion polymorphism in the proximal promoter of CD3G is associated with susceptibility for hepatocellular carcinoma in Chinese population
- PMID: 22731821
- PMCID: PMC3429282
- DOI: 10.1089/dna.2012.1706
A functional insertion/deletion polymorphism in the proximal promoter of CD3G is associated with susceptibility for hepatocellular carcinoma in Chinese population
Abstract
Hepatocellular carcinoma (HCC) represents the most common primary malignancy of the liver with a worldwide increasing incidence. Although the risk factors for HCC are well characterized, the molecular mechanisms responsible for malignant transformation of hepatocytes are not well understood. In this study, a case-control study including 291 HCC patients and 294 healthy controls was conducted to investigate the association between HCC susceptibility and with a 4-bp insertion/deletion polymorphism (rs66465034) in the proximal promoter of CD3G. Logistic regression analysis showed that the heterozygote and the homozygote 4-bp ins/ins confer a significantly increased risk of HCC after controlling for other covariates (adjusted odds ratio [OR]=1.51, 95% confidence interval [C.I.] 1.01-2.27, p=0.040; OR=1.71, 95% C.I. 1.07-2.89, p=0.025, respectively). Carriage of the 4-bp insertion allele was associated with a greatly increased risk of developing the disease (OR=1.30, 95% C.I. 1.02-1.64, p=0.027). Moreover, hepatitis B virus (HBV) stratification analysis showed that the differences between cases and controls were more obvious in HBV-positive than in the HBV-negative population, suggesting a possible role of this polymorphism in the immune regulation during HBV infection. Further, luciferase-based transient transfection assays revealed that rs66465034 can affect promoter activity of CD3G, indicating its possible functional significance. Our data suggested that common genetic polymorphisms in CD3G may influence HCC risk in Chinese population. Considering the relative small sample size, replication in other populations with larger sample size and further functional analysis are required for fully understanding the roles of CD3G polymorphisms in predisposition for HCC.
Figures


Similar articles
-
A functional insertion/deletion polymorphism in the promoter of PDCD6IP is associated with the susceptibility of hepatocellular carcinoma in a Chinese population.DNA Cell Biol. 2013 Aug;32(8):451-7. doi: 10.1089/dna.2013.2061. Epub 2013 Jun 18. DNA Cell Biol. 2013. PMID: 23777424
-
A 40-bp insertion/deletion polymorphism in the constitutive promoter of MDM2 confers risk for hepatocellular carcinoma in a Chinese population.Gene. 2012 Apr 10;497(1):66-70. doi: 10.1016/j.gene.2012.01.004. Epub 2012 Jan 18. Gene. 2012. PMID: 22285926
-
Association of HLA-G 3' UTR 14-bp insertion/deletion polymorphism with hepatocellular carcinoma susceptibility in a Chinese population.DNA Cell Biol. 2011 Dec;30(12):1027-32. doi: 10.1089/dna.2011.1238. Epub 2011 May 25. DNA Cell Biol. 2011. PMID: 21612396
-
PNPLA3 rs738409 is not associated with the risk of hepatocellular carcinoma and persistent infection of hepatitis B virus (HBV) in HBV-related subjects: A case-control study and meta-analysis on Asians.Gene. 2020 Jun 5;742:144585. doi: 10.1016/j.gene.2020.144585. Epub 2020 Mar 13. Gene. 2020. PMID: 32173542
-
Relationship between the rs2596542 polymorphism in the MICA gene promoter and HBV/HCV infection-induced hepatocellular carcinoma: a meta-analysis.BMC Med Genet. 2019 Aug 16;20(1):142. doi: 10.1186/s12881-019-0871-2. BMC Med Genet. 2019. PMID: 31419949 Free PMC article. Review.
Cited by
-
Development and evaluation of an ovarian cancer prognostic model based on adaptive immune-related genes.Medicine (Baltimore). 2025 Apr 4;104(14):e42030. doi: 10.1097/MD.0000000000042030. Medicine (Baltimore). 2025. PMID: 40193636 Free PMC article.
-
Naturally Occurring Genetic Alterations in Proximal TCR Signaling and Implications for Cancer Immunotherapy.Front Immunol. 2021 May 3;12:658611. doi: 10.3389/fimmu.2021.658611. eCollection 2021. Front Immunol. 2021. PMID: 34012443 Free PMC article. Review.
-
CD3D: a prognostic biomarker associated with immune infiltration and immunotherapeutic response in head and neck squamous cell carcinoma.Bioengineered. 2022 May;13(5):13784-13800. doi: 10.1080/21655979.2022.2084254. Bioengineered. 2022. PMID: 35712757 Free PMC article.
-
The Interplay between T Cells and Cancer: The Basis of Immunotherapy.Genes (Basel). 2023 Apr 28;14(5):1008. doi: 10.3390/genes14051008. Genes (Basel). 2023. PMID: 37239368 Free PMC article. Review.
-
Immunological analysis and differential genes screening of venous thromboembolism.Hereditas. 2021 Jan 2;158(1):2. doi: 10.1186/s41065-020-00166-6. Hereditas. 2021. PMID: 33388092 Free PMC article.
References
-
- Allen R.C. Graves G. Budowle B. Polymerase chain reaction amplification products separated on rehydratable polyacrylamide gels and stained with silver. Biotechniques. 1989;7:736–744. - PubMed
-
- Capurro M. Wanless I.R. Sherman M. Deboer G. Shi W. Miyoshi E. Filmus J. Glypican-3: a novel serum and histochemical marker for hepatocellular carcinoma. Gastroenterology. 2003;125:89–97. - PubMed
-
- Chen S. He Y. Ding J. Jiang Y. Jia S. Xia W. Zhao J. Lu M. Gu Z. Gao Y. An insertion/deletion polymorphism in the 3′ untranslated region of beta-transducin repeat-containing protein (betaTrCP) is associated with susceptibility for hepatocellular carcinoma in Chinese. Biochem Biophys Res Commun. 2010;391:552–556. - PubMed
-
- Clifford R.J. Zhang J. Meerzaman D.M. Lyu M.S. Hu Y. Cultraro C.M. Finney R.P. Kelley J.M. Efroni S. Greenblum S.I. Nguyen C.V. Rowe W.L. Sharma S. Wu G. Yan C. Zhang H. Chung Y.H. Kim J.A. Park N.H. Song I.H. Buetow K.H. Genetic variations at loci involved in the immune response are risk factors for hepatocellular carcinoma. Hepatology. 2010;52:2034–2043. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical